🇯🇵 SyB C-0501 in Japan

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SyB C-0501 (SyB C-0501) regulatory status in Japan.

Marketing authorisation

PMDA

Application: Treakisym Partial Change Approval
Local brand name: Treakisym Partial Change Approval
Status: approved

Read official source →

Frequently asked questions

Is SyB C-0501 approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for SyB C-0501 in Japan?

SymBio Pharmaceuticals is the originator. The local marketing authorisation holder may differ — check the official source linked above.